电邮这篇文章 THE EXPERIENCE OF DIAGNOSTICS AND TREATMENT OF A SYNDROME OF KASABACH-MERRITT AT CHILDREN ON THE FIRST YEAR OF LIFE
- 作者: Tokarev P.1,2, Saleev R.2, Shulaev A.2, Plaksina L.1, Safin N.1
-
隶属关系:
- «Republican Children’s Clinical Hospital Ministry of Health of Tatarstan»
- «Kazan State Medical University» of the Ministry of Public Health of the Russian Federation
- 期: 卷 23, 编号 2 (2019)
- 页面: 69-71
- 栏目: Articles
- URL: https://journals.rcsi.science/1728-2802/article/view/43041
- DOI: https://doi.org/10.18821/1728-2802-2019-23-2-69-71
- ID: 43041
如何引用文章
全文:
详细
作者简介
P. Tokarev
«Republican Children’s Clinical Hospital Ministry of Health of Tatarstan»; «Kazan State Medical University» of the Ministry of Public Health of the Russian Federation420011, Kazan; 420012, Kazan
Rinat Saleev
«Kazan State Medical University» of the Ministry of Public Health of the Russian Federation
Email: rinat.saleev@gmail.com
Dr Med. Sci., Dean of Faculty of Dentistry of Kazan State Medical University Federal State Budgetary Educational Institution of Higher Education of the Ministry of Health of Russia, 420012, Kazan, Russia 420012, Kazan
A. Shulaev
«Kazan State Medical University» of the Ministry of Public Health of the Russian Federation420012, Kazan
L. Plaksina
«Republican Children’s Clinical Hospital Ministry of Health of Tatarstan»420011, Kazan
N. Safin
«Republican Children’s Clinical Hospital Ministry of Health of Tatarstan»420011, Kazan
参考
- Поляев Ю.А., Постников С.С., Мыльников А.А., Гарбузов Р.В., Нарбутов А.Г., Шимановский Н.Л. Новые возможности в лечении инфантильных гемангиом с помощью пропранолола. Международный медицинский журнал. 2012; 2: 94-103.
- Leaute-Labreze C., Prey S., Ezzedine K. Infantile haemangioma: Part II. Risks, complications and treatment. J. Eur. Acad. Dermato.l Venerol. 2011; 25: 1254 - 60.
- Oak S.N., Viswanath K. Management of hemangioma in children. Indian J. Dermatol. Venerol. Leprol. 2006; 18 (72): 1-4.
- Zvulunov A., McCuaig C., Frieden I.J., et al. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study. Pediatr. Dermatol. 2011; 28 (2): 94-8.
- Leaute-Labreze C., Dumas de la Roque E., Hubiche T., et al. Propranolol for severe hemangiomas of infancy. N. Engl. J. Med. 2008; 358 (24): 2649 - 51.
- Kilkline C., Frieden I.J. Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr. Dermatol. 2008; 25: 168 - 73.
- Buckmiller L.M., Munsun. P.D., Dyamenahalli U., et al. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope. 2010; 120: 676 - 81.
- Stroch C. H., Hoeger P.H. Propranolol for infantile hemangiomas: insights into the molecular mechanisms of actions. Br. J. Dermatol. 2010; 163(2): 269 -74.
- Schiestl C., Neuhaus K. , Zoller S. et al. Efficacy and safety of propranolol at first - line treatment for infantile hemangiomas. Eur. J. Pediatr. 2011; 170 (4): 493 - 501.
- Leonardi-Bee J., Batta K., O’Brien C., Bath-Hextall F.J. Intervenous for infantile hemangiomas (strawberry birth marks) of the skin. Cochrane Database Syst Rev. 2011; (5): CD006545.
